Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Resveratrol and Reduced Disability

Doses used in studies

mg/day: 50 (median 50, IQR 50–50) — 1 study

Time to effect

Median: 4.3 weeks · IQR 4.3 weeks–4.3 weeks · Range 4.3 weeks–4.3 weeks — Reported in 1 of 1 study

1 of 1 paper

Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial.
- 2023-12-18
- RCT · n = 128
- Medicina (Kaunas, Lithuania) 59(12)
- - Dalila Scaturro
  - Fabio Vitagliani
  - Sofia Tomasello
  - Cristiano Sconza
  - Stefano Respizzi
  - Giulia Letizia Mauro
- PubMed: 38138300
- DOI: 10.3390/medicina59122197
2 Insights on
- Reduced Disability
- High evidence
- Large Human Trial
- Clinical
At T1, the Combo group showed statistically superior results compared to the other groups for disability (p < 0.05).
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
800 IU/day